Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone

被引:285
作者
Allen, C
Han, JN
Yu, YS
Maysinger, D
Eisenberg, A
机构
[1] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada
[2] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
drug delivery; dihydrotestosterone; block copolymer micelles; polycaprolactone-b-poly(ethylene oxide);
D O I
10.1016/S0168-3659(99)00200-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Block copolymer micelles formed from copolymers of poly(caprolactone)-b-poly(ethylene oxide) (PCL-b-PEO) were investigated as a drug delivery vehicle for dihydrotestosterone (DHT). The physical parameters of the PCL-b-PEO micelle-incorporated DHT were measured, including the loading capacity of the micelles for DHT, the apparent partition coefficient of DHT between the micelles and the external medium and the kinetics of the release of DHT from the micelle solution. The MTT survival assay was used to assess the in vitro biocompatibility of PCL-b-PEO micelles in HeLa cell cultures. The biological activity of the micelle-incorporated DHT was evaluated in HeLa cells which had been co-transfected with the expression vectors for the androgen receptor and the MMTV-LUC reporter gene. The PCL-b-PEO micelles were found to have a high loading capacity for DHT and the release profile of the drug from the micelle solution was found to be a slow steady release which continued over a 1-month period. The biological activity of the micelle-incorporated DHT was found to be fully retained. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:275 / 286
页数:12
相关论文
共 39 条
  • [1] Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer
    Alakhov, VY
    Moskaleva, EY
    Batrakova, EV
    Kabanov, AV
    [J]. BIOCONJUGATE CHEMISTRY, 1996, 7 (02) : 209 - 216
  • [2] Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818
    Allen, C
    Yu, YS
    Maysinger, D
    Eisenberg, A
    [J]. BIOCONJUGATE CHEMISTRY, 1998, 9 (05) : 564 - 572
  • [3] ALLEN C, 1999, BIOCHIM BIOPHYS ACTA, V1421, P28
  • [4] ALLEN C, 1999, IN PRESS NANOENGINEE
  • [5] Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men
    Arver, S
    Dobs, AS
    Meikle, AW
    Caramelli, KE
    Rajaram, L
    Sanders, SW
    Mazer, NA
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 47 (06) : 727 - 737
  • [6] A BIODEGRADABLE TESTOSTERONE MICROCAPSULE FORMULATION PROVIDES UNIFORM EUGONADAL LEVELS OF TESTOSTERONE FOR 10-11 WEEKS IN HYPOGONADAL MEN
    BHASIN, S
    SWERDLOFF, RS
    STEINER, B
    PETERSON, MA
    MERIDORES, T
    GALMIRINI, M
    PANDIAN, MR
    GOLDBERG, R
    BERMAN, N
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (01) : 75 - 83
  • [7] The application of microspheres from the copolymers of lactide and ε-caprolactone to the controlled release of steroids
    Buntner, B
    Nowak, M
    Kasperczyk, J
    Ryba, M
    Grieb, P
    Walski, M
    Dobrzyñski, P
    Bero, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 56 (1-3) : 159 - 167
  • [8] LONGITUDINAL EVALUATION OF SERUM ANDROGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE-CANCER
    CARTER, HB
    PEARSON, JD
    METTER, EJ
    CHAN, DW
    ANDRES, R
    FOZARD, JL
    ROSNER, W
    WALSH, PC
    [J]. PROSTATE, 1995, 27 (01) : 25 - 31
  • [9] COR W, 1996, ENDOCRINOLOGY, V37, P1870
  • [10] Water-soluble hollow nanospheres as potential drug carriers
    Ding, JF
    Liu, GJ
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 1998, 102 (31) : 6107 - 6113